Evidence map›Paper›PMID 41091446›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Evaluation of VITEK 2 and three protocols for direct susceptibility testing on Gram-negative bacilli from positive blood culture bottles.

Özlem Aydemir, Belgin Eda Misi, Hatice Erdal, Müge Arıcan, Şeyma Arabacıgil Hıdır, Şeyda Durna, İhsan Hakkı Çiftçi, Mehmet Köroğlu

Abstract readEvaluation StudyComparative Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Özlem AydemirSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey. ozlemaydemir@sakarya.edu.tr.
Belgin Eda MisiSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey.
Hatice ErdalSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey.
Müge ArıcanSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey.
Şeyma Arabacıgil HıdırSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey.
Şeyda DurnaMinistry of Health and Sakarya University Education and Research Hospital Department of Medical Microbiology Laboratory, Sakarya, Turkey.
İhsan Hakkı ÇiftçiSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey.
Mehmet KöroğluSakarya University Faculty of Medicine Department of Medical Microbiology, Sakarya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBloodstream infections are associated with high mortality, while early and appropriate antibiotic therapy can significantly reduce fatal outcomes. Direct antibiotic susceptibility testing (AST) from positive blood cultures has the potential to enable earlier administration of antimicrobials compared with routine AST. The aim of the study was to evaluate the performance of three direct AST protocols for Gram-negative bacilli using positive blood culture fluids.

methodsAST performed on subcultured isolates with VITEK 2 was defined as protocol 1 and used as the reference method. From positive blood culture bottles signaling Gram-negative bacilli, VITEK 2 (protocol 2), modified disk diffusion (protocol 3) and rapid disk diffusion (protocol 4) recommended by EUCAST. The results of protocols 2, 3 and 4 were compared with protocol 1.

resultsThe categorical agreements (CA) of protocols 2, 3, and 4 compared with protocol 1 for all strains were 95.9%, 80.7%, and 80.6%, respectively. Very major discrepancy (VMD) rates were 0.5%, 9%, and 1%, major discrepancy (MD) rates were 2.5%, 2.9%, and 6.9%, while minor discrepancy rates were 2.4%, 3.7%, and 3.5%, respectively.

conclusionVITEK 2 AST performed directly from blood culture bottles demonstrated the highest categorical agreement and the lowest discrepancy rates across all isolates and antibiotics. This approach is practical in laboratories equipped with mass spectrometry for direct identification and offers a cost-effective option for widespread use in clinical microbiology settings.

Indexed as

Anti-Bacterial AgentsBacteremiaBlood CultureGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansMicrobial Sensitivity TestsAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.